Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

BACKGROUND: Interferon (IFN) beta-1a is an approved treatment for relapsing remitting multiple sclerosis (RRMS) and has been examined for use in secondary progressive multiple sclerosis (SPMS). However, no information regarding blood transcriptional changes induced by IFN treatment in SPMS patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Neurol
Main Authors: Gurevich, Michael, Miron, Gadi, Falb, Rina Zilkha, Magalashvili, David, Dolev, Mark, Stern, Yael, Achiron, Anat
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654830/
https://ncbi.nlm.nih.gov/pubmed/26589141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0495-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados